Heron Therapeutics (0J4V.LSE) Q4 2023 Earnings

12MarConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.15
-0.13
-0.1
-0.07

Details

Expected EPS
-0.153833
Actual EPS
-0.07
Surprise EPS
0.08
Surprise Percent
+54.5%

Description

Heron Therapeutics (0J4V.LSE) has reported earnings of -0.07 per share for Q4 2023.

0 Comments

Share your thoughts